Update 4/24/2024: NIA Funding Line Policy for FY 2024
On Saturday, March 23, 2024, the President signed into law: H.R. 2882, the “Further Consolidated Appropriations Act, 2024,” which provides funding through September 30, 2024, for all departments and agencies of the Federal Government, including the NIH. NIA has updated the funding line policy below to reflect the actual 2024 budget allocation. As always, please watch this page for further updates as they become available.
It is the intent of NIA that we will now pay all FY24 noncompeting awards at 100% of the committed level as shown in the Notice of Award. NIA will also restore the cuts made in noncompeting awards paid earlier in this fiscal year.
Note: There is always a possibility that changes will be made to the payline before the end of the fiscal year.
General Allocation
NIA is now reducing FY24 competing awards by 16% on average. This average-cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards), and R15s (Academic Research Enhancement Awards and the NIH Research Enhancement Awards program). These awards (R03, R21, R15) generally receive the study-section-recommended amount of support. Additionally, all early stage investigator (ESI) and new investigator (NI) applications will not receive the reduction and will receive the study-section-recommended amount of support.
Note: The 16% cut remains an average. Individual awards may be reduced by more or less than that percentage.
Alzheimer’s Allocation
NIA is paying awards at their full study-section-recommended amounts, unless concerns about overlap or similar issues reduce the amount awarded.
Paylines
| General payline, < $500K | General payline, ≥ $500K | ADRD payline, < $5M | ADRD payline, ≥ $5M | |
|---|---|---|---|---|
| All (except below) | 16% | 13% | 17% | 14% |
| New investigator R01s | 19% | 16% | 20% | 17% |
| Early Stage Investigator R01s | 21% | 18% | 22% | 19% |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may alternatively provide short-term support (R56) or invite a resubmission of the application. Similarly, we may pay a few applications beyond the paylines when they focus on high priorities of the institute.
| Applications | General payline | AD/ADRD payline |
|---|---|---|
| Program projects | 25 | 25 |
| Other NIA-reviewed research | 25 | 25 |
| Parent career development awards | 22 | 30 |
| Parent fellowship awards | 30 | 35 |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may invite a resubmission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the institute.
All other categories of awards (Conference, Institutional Training, Small Business) are allocation-based rather than based on a funding line.
Last updated: April 24, 2024